Lv0
0 积分 2025-07-11 加入
Real-World Efficacy and Safety of Glofitamab-Based Salvage Therapy in Chinese Patients With Relapsed or Refractory Aggressive B-Cell Lymphomas
1小时前
待确认
The future of follicular lymphoma management: strategies on the horizon
2个月前
已完结
Early versus standard management of chimeric antigen receptor therapy toxicities and management's impact on safety and efficacy
5个月前
已完结
How I Treat Cytopenias after CAR T-cell Therapy
5个月前
已完结
Definition, Diagnosis, and Management of Intravascular Large B-Cell Lymphoma: Proposals and Perspectives From an International Consensus Meeting
7个月前
已完结
Sequential Targeting in Multiple Myeloma: Talquetamab, a GPRC5D bispecific antibody, as a Bridge to BCMA CAR-T cell therapy
10个月前
已完结
A phase 1 trial of prizloncabtagene autoleucel, a CD19/CD20 CAR T-cell therapy for relapsed/refractory B-cell non-Hodgkin lymphoma
11个月前
已完结
皖公网安备34019202002308
